Valuation: Aprogen Medicines Inc.

Market Cap 4.31TCr 3.21Cr 2.88Cr 2.66Cr 2.41Cr 4.5Cr 305.29Cr 4.55Cr 32Cr 13Cr 159.75Cr 12Cr 12Cr 507.15Cr P/E 2024
-3.44x
P/E 2025 -2.95x
Enterprise Value 18TCr 13Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 132.94Cr 53Cr 668.04Cr 50Cr 49Cr 2.12TCr EV / Sales 2024
1.93x
EV / Sales 2025 2.99x
Free-Float
61.67%
Yield 2024 *
-
Yield 2025 -
23/09 Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
23/09 Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
21/09 Aprogen Medicines Inc.(KOSE:A007460) dropped from S&P Global BMI Index CI
03/09 Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc. CI
03/09 Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc. CI
21/08 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding from Jade New Technology Association CI
14/08 Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
10/08 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding from Jade New Technology Association CI
27/07 Aprogen Biologics Inc. announced that it has received KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
23/07 Aprogen Medicines Inc. announced that it has received KRW 2 billion in funding CI
14/07 Aprogen Medicines to Raise 2 Billion Won Through Convertible Bond Issue MT
14/07 Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen Medicines Inc. CI
14/07 Aprogen Medicines Inc. announced that it expects to receive KRW 2 billion in funding CI
1 day+1.36%
1 week-0.67%
Current month+0.73%
1 month-3.48%
3 months-16.20%
6 months-55.86%
Current year-81.44%
1 week 1,841
Extreme 1841
1,987
1 month 1,841
Extreme 1841
2,335
Current year 1,841
Extreme 1841
11,880
1 year 1,841
Extreme 1841
14,070
3 years 1,841
Extreme 1841
28,410
5 years 1,841
Extreme 1841
94,950
10 years 1,841
Extreme 1841
8,75,250
Manager TitleAgeSince
Chief Executive Officer 63 27/12/2017
Comptroller/Controller/Auditor 69 28/03/2018
Director TitleAgeSince
Director/Board Member 63 29/11/2022
Director/Board Member 64 18/07/2022
Director/Board Member 62 13/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/01/25 Others 7,673 0.0025% -
19/01/24 Free 1,01,429 0.0383%
19/01/24 Free 1,98,187 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
+1.36%-0.67%-79.07%-86.39% 3.2Cr
+1.32%-4.77%+18.97%+146.93% 11TCr
+0.46%-2.75%+12.51%+31.25% 8.81TCr
-0.16%-0.77%+39.23%+84.76% 6.32TCr
+1.99%-2.03%+23.53%+76.63% 5.91TCr
-0.17%-1.58%+97.58%+180.57% 5.72TCr
+1.51%+2.07%+18.80%+60.50% 3.41TCr
-0.01%-4.20%-3.94%+25.05% 2.93TCr
+0.85%+4.02%+15.67%+61.87% 2.74TCr
-4.00%-16.94%-41.31%-1.05% 2.14TCr
Average +0.36%-1.54%+10.20%+58.01% 4.94TCr
Weighted average by Cap. +0.60%-1.82%+25.90%+89.43%

Financials

2024 2025
Net sales 15TCr 11Cr 10Cr 9.26Cr 8.39Cr 16Cr 1.06TCr 16Cr 110.75Cr 44Cr 556.53Cr 42Cr 41Cr 1.77TCr 12TCr 8.78Cr 7.87Cr 7.28Cr 6.59Cr 12Cr 835.84Cr 12Cr 87Cr 35Cr 437.38Cr 33Cr 32Cr 1.39TCr
Net income -5.81TCr -4.32Cr -3.88Cr -3.58Cr -3.25Cr -6.06Cr -411.49Cr -6.14Cr -43Cr -17Cr -215.32Cr -16Cr -16Cr -683.57Cr -7.02TCr -5.22Cr -4.69Cr -4.33Cr -3.92Cr -7.33Cr -497.38Cr -7.42Cr -52Cr -21Cr -260.27Cr -20Cr -19Cr -826.26Cr
Net Debt 7TCr 5.21Cr 4.67Cr 4.32Cr 3.91Cr 7.31Cr 496.23Cr 7.4Cr 52Cr 21Cr 259.67Cr 20Cr 19Cr 824.36Cr 14TCr 10Cr 9.15Cr 8.46Cr 7.66Cr 14Cr 971.36Cr 14Cr 101.15Cr 40Cr 508.29Cr 38Cr 37Cr 1.61TCr
Projected Income Statement - Annual - Aprogen Medicines Inc.
Logo Aprogen Medicines Inc.
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Employees
160
Date Price Change Volume
28/26/28 ₩1,940.00 +1.36% 3,73,051
27/26/27 ₩1,914.00 -0.73% 38,622
26/26/26 ₩1,928.00 +1.47% 52,239
23/26/23 ₩1,900.00 -1.04% 99,154
22/26/22 ₩1,920.00 -1.54% 54,551
  1. Stock Market
  2. Stocks
  3. A007460 Stock